The 2026 proposal is seemingly shifting the TRT landscape, moving it further from the "use with caution" territory.

While some research has shown benefits for patients who qualify, questions remain about the therapy's long-term risks and use among men without a medical need.

Federal regulators are moving to rewrite the rulebook on testosterone replacement therapy, easing warnings that have shaped ...

Men with low-risk prostate cancer and hypogonadism may safely receive testosterone therapy Testosterone saturation model suggests limited cancer growth stimulation by normal hormone levels Studies ...

Doctors raised a range of concerns about a testosterone screening policy announced by Defense Secretary Pete Hegseth, which is likely to be costly to implement.

The military plans to start screening service members for low testosterone, and social media is overflowing with claims about ...

The Pentagon's new testosterone screening policy will test troops over 30. A doctor explains what the research shows about risks, benefits, and who qualifies for therapy.

Andropause is diagnosable, but not casually. A morning blood draw is the beginning of the process.

Interest in testosterone replacement therapy keeps climbing, and the TRAVERSE trial remains the largest randomized test of ...

In a population of middle-aged and older men with hypogonadism, "the incidences of high-grade or any prostate cancer and other prostate events were low and did not differ significantly between ...

To diagnose low testosterone, doctors look at physical health, evaluate symptoms and order several blood tests for hormonal ...